Bio-Gene Technology (ASX: BGT) Share Price

BGT

$0.022▲+10.00%

$5.9MRank #1636 on ASXHealthcareBiotechnology

Prices updated 13 June 2026, 9:40 am AEST · Data: Financial Modeling Prep

Market Cap

$5.9M

Volume

574K

P/E Ratio

-1.25

EPS

-$0.0046

Dividend Yield

0.00%

52-Week High

$0.061

52-Week Low

$0.016

Beta

0.736

Bio-Gene Technology (ASX: BGT) is an Australian-listed company in the Healthcare sector with a market capitalisation of $5.9M and the 1636th-largest security on the ASX by market capitalisation. The BGT share price is $0.022, up 10.00% today and up 10.00% over the past 12 months. Shares have traded between $0.016 and $0.061 over the past 52 weeks. In its most recent reported period (ending 31 Dec 2025), Bio-Gene Technology reported revenue of $0 and a net loss of $1.4M.

Charts

$0.02

24H Range

$0.021

$0.022

52-Week Range

$0.016

$0.061

About Bio-Gene Technology Limited

Bio-Gene Technology Limited, an agricultural technology firm based in Australia, focuses on the development and commercialization of insecticides and pesticides. These solutions are designed for a range of uses, encompassing animal health, crop protection, public health, and consumer applications. The company's key products include Flavocide, an insecticide utilizing beta-triketone technology, and Qcide, a natural oil derived from a specific cultivar of eucalyptus cloeziana. Bio-Gene maintains a research partnership with James Cook University to develop a tissue culture system, a critical step for expanding tree plantations and increasing future Qcide oil production. Furthermore, the company collaborates with BASF, the Grains Research and Development Corporation, and the Queensland Department of Agriculture and Fisheries to assess its products' effectiveness against grain storage pests. Established in 1995, Bio-Gene Technology Limited operates from its headquarters in Melbourne, Australia.

IPO Date

28 Nov 2017

CEO

Timothy Owen Grogan

Website

bio-gene.com.au

Key Financial Data

Revenue (Quarterly)	$0
Net Income (Quarterly)	$-1.4M
Total Assets	$1.5M
Total Debt	$0
Free Cash Flow	$-946,610
Return on Equity	-120.05%
Profit Margin	—
Operating Margin	—

BGT Frequently Asked Questions

What is the Bio-Gene Technology (ASX: BGT) share price?

The BGT share price is $0.022, up 10.00% for the day, based on the latest available ASX market data.

What is Bio-Gene Technology's market capitalisation?

Bio-Gene Technology has a market capitalisation of $5.9M, making it the 1636th-largest security listed on the ASX.

Does Bio-Gene Technology pay a dividend?

BGT does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Bio-Gene Technology profitable?

In its most recent reported period (ending 31 Dec 2025), BGT reported revenue of $0 and a net loss of $1.4M.

How many BGT shares are on issue?

Bio-Gene Technology has approximately 270,244,773 shares on issue, based on its market capitalisation of $5.9M and current share price.

What sector is Bio-Gene Technology in?

Bio-Gene Technology is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Bio-Gene Technology list on the ASX?

Bio-Gene Technology listed on the Australian Securities Exchange on 28 Nov 2017.

Latest News

Insights: Bio-Gene Technology Ltd (ASX:BGT)

smallcaps.com.au30 Oct 2025

Insights: Bio-Gene Technology Ltd (ASX:BGT) smallcaps.com.au

Insider Stock Buying Of Bio-Gene Technology Delivers Return On AU$815.0k Investment

simplywall.st2 Dec 2025

Insider Stock Buying Of Bio-Gene Technology Delivers Return On AU$815.0k Investment simplywall.st

Bio-Gene Technology Ltd (ASX: BGT) - Announcements

intelligentinvestor.com.au27 Sept 2019

Bio-Gene Technology Ltd (ASX: BGT) - Announcements intelligentinvestor.com.au